Discover Astex
Our Mission & Values
Our Leadership Team
Harren Jhoti
David Rees
John Lyons
Chris Murray
Jeremy Carmichael
Tom Heightman
Neil Jones
Nicola Wallis
Nicola Wilsher
Mohammad Azab
Martin Buckland
Harold N. Keer
Nipun Davar
Yong Hao
Joseph Iovino
Samuel Jason
Charles LaPree
Shinichi Sato
Nancy Worrell
Our History
Corporate Social Responsibility
R&D
Clinical Pipeline
Guadecitabine (SGI-110) DNMT inhibitor (Treatment Naïve AML)
Guadecitabine (SGI-110) DNMT inhibitor (Relapsed/Refractory AML)
Guadecitabine (SGI-110) DNMT inhibitor (Relapsed/Refractory MDS or CMML)
Guadecitabine (SGI-110) DNMT inhibitor (Solid Tumors)
ASTX029 Extracellular Signal-Related Protein Kinases (ERK 1/2) Inhibitor (Solid Tumors)
ASTX727 Oral DNMT inhibitor (Hematologic Malignancies)
ASTX660 Dual IAP Antagonist (Solid Tumors & Lymphomas)
Kisqali®(ribociclib) CDK4/6 inhibitor (Oncology)
AZD5363 PKB/Akt Inhibitor (Oncology)
JNJ42756493 (erdafitinib) FGFr inhibitor (Oncology)
Multiple Targets and Therapeutic Areas
Pyramid™ Discovery Platform
Oncology and CNS Discovery
Sustaining Innovation
Partnering
Our People
Career Opportunities
Media
Press Releases
Press Releases – Archive
Conferences & Meetings
Presentations & Publications
Astex in the News
Contact
Search
Menu
You are here:
Home
/
Our People & Culture
/
Current US Openings
Current Career Opportunities
Current Career
Opportunities
Scroll to top
By continuing to use this website you will be agreeing to our
Terms & Conditions
, our
Privacy Policy
, and the use of cookies.
continue
